Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Antidepressants Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Tricyclic Antidepressants
  • 1.3.3 Selective Serotonin Reuptake Inhibitors
  • 1.3.4 Selective Norepinephrine Reuptake Inhibitors
  • 1.3.5 Monoamine Oxidase Inhibitors
  • 1.3.6 Benzodiazepines
  • 1.3.7 Antipsychotics
  • 1.3.8 Novel Agents
• 1.4 Market Segment by Application
  • 1.4.1 Global Antidepressants Market Share by Application (2019-2025)
  • 1.4.2 Hospitals
  • 1.4.3 Clinics
  • 1.4.4 Other
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Antidepressants Market Size
  • 2.1.1 Global Antidepressants Revenue 2014-2025
  • 2.1.2 Global Antidepressants Sales 2014-2025
• 2.2 Antidepressants Growth Rate by Regions
  • 2.2.1 Global Antidepressants Sales by Regions 2014-2019
  • 2.2.2 Global Antidepressants Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Antidepressants Sales by Manufacturers
  • 3.1.1 Antidepressants Sales by Manufacturers 2014-2019
  • 3.1.2 Antidepressants Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Antidepressants Revenue by Manufacturers (2014-2019)
  • 3.2.2 Antidepressants Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Antidepressants Market Concentration Ratio (CR5 and HHI)
• 3.3 Antidepressants Price by Manufacturers
• 3.4 Key Manufacturers Antidepressants Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Antidepressants Market
• 3.6 Key Manufacturers Antidepressants Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Tricyclic Antidepressants Sales and Revenue (2014-2019)
  • 4.1.2 Selective Serotonin Reuptake Inhibitors Sales and Revenue (2014-2019)
  • 4.1.3 Selective Norepinephrine Reuptake Inhibitors Sales and Revenue (2014-2019)
  • 4.1.4 Monoamine Oxidase Inhibitors Sales and Revenue (2014-2019)
  • 4.1.5 Benzodiazepines Sales and Revenue (2014-2019)
  • 4.1.6 Antipsychotics Sales and Revenue (2014-2019)
  • 4.1.7 Novel Agents Sales and Revenue (2014-2019)
• 4.2 Global Antidepressants Sales Market Share by Type
• 4.3 Global Antidepressants Revenue Market Share by Type
• 4.4 Antidepressants Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Antidepressants Sales by Application

6 United States

• 6.1 United States Antidepressants Breakdown Data by Company
• 6.2 United States Antidepressants Breakdown Data by Type
• 6.3 United States Antidepressants Breakdown Data by Application

7 European Union

• 7.1 European Union Antidepressants Breakdown Data by Company
• 7.2 European Union Antidepressants Breakdown Data by Type
• 7.3 European Union Antidepressants Breakdown Data by Application

8 China

• 8.1 China Antidepressants Breakdown Data by Company
• 8.2 China Antidepressants Breakdown Data by Type
• 8.3 China Antidepressants Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Antidepressants Breakdown Data by Company
• 9.2 Rest of World Antidepressants Breakdown Data by Type
• 9.3 Rest of World Antidepressants Breakdown Data by Application
• 9.4 Rest of World Antidepressants Breakdown Data by Countries
  • 9.4.1 Rest of World Antidepressants Sales by Countries
  • 9.4.2 Rest of World Antidepressants Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 H Lundbeck
  • 10.1.1 H Lundbeck Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Antidepressants
  • 10.1.4 Antidepressants Product Introduction
  • 10.1.5 H Lundbeck Recent Development
• 10.2 Astrazeneca
  • 10.2.1 Astrazeneca Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Antidepressants
  • 10.2.4 Antidepressants Product Introduction
  • 10.2.5 Astrazeneca Recent Development
• 10.3 Eli Lilly and Company
  • 10.3.1 Eli Lilly and Company Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Antidepressants
  • 10.3.4 Antidepressants Product Introduction
  • 10.3.5 Eli Lilly and Company Recent Development
• 10.4 Sun Pharmaceuticals
  • 10.4.1 Sun Pharmaceuticals Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Antidepressants
  • 10.4.4 Antidepressants Product Introduction
  • 10.4.5 Sun Pharmaceuticals Recent Development
• 10.5 Pfizer Inc.
  • 10.5.1 Pfizer Inc. Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Antidepressants
  • 10.5.4 Antidepressants Product Introduction
  • 10.5.5 Pfizer Inc. Recent Development
• 10.6 GlaxoSmithKline
  • 10.6.1 GlaxoSmithKline Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Antidepressants
  • 10.6.4 Antidepressants Product Introduction
  • 10.6.5 GlaxoSmithKline Recent Development
• 10.7 Bristol-Myers Squibb Company
  • 10.7.1 Bristol-Myers Squibb Company Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Antidepressants
  • 10.7.4 Antidepressants Product Introduction
  • 10.7.5 Bristol-Myers Squibb Company Recent Development
• 10.8 Johnson & Johnson
  • 10.8.1 Johnson & Johnson Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Antidepressants
  • 10.8.4 Antidepressants Product Introduction
  • 10.8.5 Johnson & Johnson Recent Development
• 10.9 Merck
  • 10.9.1 Merck Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Antidepressants
  • 10.9.4 Antidepressants Product Introduction
  • 10.9.5 Merck Recent Development
• 10.10 Sanofi
  • 10.10.1 Sanofi Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Antidepressants
  • 10.10.4 Antidepressants Product Introduction
  • 10.10.5 Sanofi Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Antidepressants Sales Channels
  • 11.2.2 Antidepressants Distributors
• 11.3 Antidepressants Customers

12 Market Forecast

• 12.1 Global Antidepressants Sales and Revenue Forecast 2019-2025
• 12.2 Global Antidepressants Sales Forecast by Type
• 12.3 Global Antidepressants Sales Forecast by Application
• 12.4 Antidepressants Forecast by Regions
  • 12.4.1 Global Antidepressants Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Antidepressants Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Antidepressants is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antidepressants.

This report studies the global market size of Antidepressants, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Antidepressants sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
H Lundbeck
Astrazeneca
Eli Lilly and Company
Sun Pharmaceuticals
Pfizer Inc.
GlaxoSmithKline
Bristol-Myers Squibb Company
Johnson & Johnson
Merck
Sanofi

Market Segment by Product Type
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitors
Selective Norepinephrine Reuptake Inhibitors
Monoamine Oxidase Inhibitors
Benzodiazepines
Antipsychotics
Novel Agents

Market Segment by Application
Hospitals
Clinics
Other

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Antidepressants status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Antidepressants manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Antidepressants are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025